Doxycycline in early CJD: a double-blinded randomised phase II and observational study

OBJECTIVES: The main objective of the present study is to study the therapeutic efficiency of doxycycline in a double-blinded randomised phase II study in a cohort of patients with sporadic Creutzfeldt-Jakob disease (sCJD). METHODS: From the National Reference Center of TSE Surveillance in Germany,...

Descripción completa

Detalles Bibliográficos
Autores principales: Varges, Daniela, Manthey, Henrike, Heinemann, Uta, Ponto, Claudia, Schmitz, Matthias, Schulz-Schaeffer, Walter J, Krasnianski, Anna, Breithaupt, Maren, Fincke, Fabian, Kramer, Katharina, Friede, Tim, Zerr, Inga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Neurodegeneration
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5284486/
https://www.ncbi.nlm.nih.gov/pubmed/27807198
http://dx.doi.org/10.1136/jnnp-2016-313541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5284486/
https://www.ncbi.nlm.nih.gov/pubmed/27807198
http://dx.doi.org/10.1136/jnnp-2016-313541

Ejemplares similares